CDC: First swine flu vaccines may be nasal spray

Sep 18, 2009 By MIKE STOBBE , AP Medical Writer

(AP) -- The first doses of swine flu vaccine may all be the nasal spray version, government health officials said Friday.

The government has said a trickle of vaccine will be available in early October, but on Friday they defined the size of that trickle - an estimated 3.4 million doses.

Currently it looks like all of them will be a nasal spray vaccine that is approved only for healthy people ages 2 to 49, said Dr. Jay Butler, an official with the Centers for Disease Control and Prevention.

The nasal spray, called FluMist, is not recommended for some of the people most in danger of severe swine flu complications. That includes pregnant women, children younger than 2, and people with asthma and other chronic respiratory diseases.

However, it's possible that some vaccine shots will become available by the first week of October as well, said Butler, chief of the CDC's swine flu vaccine task force.

Flu shots are made of killed influenza virus, while FluMist is a live but weakened strain. The nasal spray is only approved in the United States, and is made by the Maryland-based MedImmune, an AstraZeneca PLC subsidiary. Four other companies are making flu shots for the U.S.

The initial vaccine doses will go to up to 90,000 sites, including schools and clinics, across the U.S. State health departments will determine which offices and clinics get the shots, and whether health care workers or others get the first doses, Butler said at a CDC press conference Friday.

The government has ordered 195 million doses but may order more if there's enough demand, health officials have said. Typically fewer than 100 million Americans get a flu vaccine every year, and it's unclear whether swine flu will prompt much more demand.

A recent Associated Press-GfK poll found 57 percent of people said they were likely to get it.

---

On the Net:

CDC: http://www.cdc.gov/h1n1flu/

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: Added benefit of vedolizumab is not proven

add to favorites email to friend print save as pdf

Related Stories

Flu season: How many shots?

Aug 30, 2009

(AP) -- Doctors don't know yet if it will take one dose or two of vaccine to protect against the new swine flu. Add that to vaccine for the regular winter flu, and it could be a multishot season for a lot of people - or ...

US swine flu deaths rise to 263

Jul 17, 2009

(AP) -- Health officials say their count of U.S. swine flu cases has surpassed 40,000, and deaths have risen to 263.

FDA approves new swine flu vaccine

Sep 15, 2009

(AP) -- The Food and Drug Administration approved the new swine flu vaccine Tuesday, a long-anticipated step as the government works to get vaccinations under way next month. Health and Human Services Secretary ...

Flu drug advised for pregnant women with swine flu

May 12, 2009

(AP) -- Pregnant women should take prescription flu medicines if they are diagnosed with the new swine flu, health officials said Tuesday. So far, the swine flu has not proven to be much more dangerous than seasonal influenza, ...

Recommended for you

Added benefit of vedolizumab is not proven

6 hours ago

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

deatopmg
1 / 5 (1) Sep 18, 2009
is it really more dangerous to those outside the guidelines than the injectable form containing squalene?? Or is money the issue here?